CRISPR–Cas9 genome editing induces a p53-mediated DNA damage response
2018 · Nature Medicine · 1,228 citations
https://doi.org/10.1038/s41591-018-0049-z
E
Emma Haapaniemi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
28
Papers
2.7K
Citations
11
h-index
11
i10-index
Emma Haapaniemi is an academic researcher from Oslo University Hospital. The author has contributed to research in topics: Immunodeficiency and Autoimmune Disorders & CRISPR and Genetic Engineering & Blood disorders and treatments. The author has an h-index of 11, co-authored 24 publications.
ORCID: 0000-0002-6693-8208Papers by this author
worksCombined immunodeficiency and hypoglycemia associated with mutations in hypoxia upregulated 1
2016 · Journal of Allergy and Clinical Immunology · 20 citations
https://doi.org/10.1016/j.jaci.2016.09.050
Protocol for editing fibroblasts with in vitro transcribed Cas9 mRNA and profile off-target editing by optimized GUIDE-seq
2023 · STAR Protocols · 2 citations
https://doi.org/10.1016/j.xpro.2023.102662
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat